Latest news
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit - PR NewswirePR Newswire · Sat, 08 Aug 2026 16:35:00 GMTCapricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR - PR NewswirePR Newswire · Sat, 08 Aug 2026 02:00:00 GMTCapricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - The Globe and MailThe Globe and Mail · Fri, 07 Aug 2026 19:26:00 GMTTangible book value per share of Capricor Therapeutics, Inc. – HAM:4LN2 - TradingViewTradingView · Fri, 07 Aug 2026 18:10:32 GMTDilution adjustment of Capricor Therapeutics, Inc. – HAM:4LN2 - TradingViewTradingView · Fri, 07 Aug 2026 17:58:49 GMTCapricor Therapeutics, Inc. Dividends – HAM:4LN2 - TradingViewTradingView · Fri, 07 Aug 2026 16:03:13 GMTKaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Seeking Recovery to Contact the Firm Before September 28, 2026 - The Globe and MailThe Globe and Mail · Fri, 07 Aug 2026 15:30:00 GMTState Street Corporation (NASDAQ: CAPR custodian) holds 5.9% of Capricor Therapeutics - Stock TitanStock Titan · Fri, 07 Aug 2026 12:54:45 GMT